ONS member Cyndy Simonson, MS, APRN-BC, AOCN®, oncology nurse practitioner who is the nursing editor at Duke Regional Hospital in Durham, NC, and member of the North Carolina Triangle ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss biomarker testing for patients with cancer and how it affects targeted therapy regimens during treatment. The advertising messages in this episode are paid for by G1 Therapeutics, Inc.

Episode Notes

Check out these resources from today’s episode:

To discuss the information in this episode with other oncology nurses, visit the ONS Communities.

To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.

Episode 169: How Biomarker Testing Drives the Use of Targeted Therapies 39:21 Share

The Oncology Nursing Podcast

Shownotes Transcript

Episode 169: How Biomarker Testing Drives the Use of Targeted Therapies